Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Kurin, Inc.

News headline image
Kurin Prevails in Federal Appellate Court in Long-Running Litigation with Magnolia Medical Technologies
From Kurin, Inc.
Via Business Wire
News headline image
Kurin Works with The Ohio State University Wexner Medical Center on Patient Safety and Increased Access to High Quality Healthcare
From Kurin, Inc.
Via Business Wire
News headline image
Final Judgment Entered in Kurin’s Favor over Magnolia Medical
From Kurin, Inc.
Via Business Wire
News headline image
Kurin Announces Appointment of Chief Commercial Officer
From Kurin, Inc.
Via Business Wire
News headline image
Court Determines that Kurin Does Not Infringe Magnolia Medical Patent
From Kurin, Inc.
Via Business Wire
News headline image
Kurin, Inc. Reports Record Revenue for Q1 2024
From Kurin, Inc.
Via Business Wire
News headline image
USPTO Examiner Affirms Rejection of Claims Asserted by Magnolia Medical, Inc. against Kurin, Inc.
From Kurin, Inc.
Via Business Wire
News headline image
USPTO Issues Final Rejection of Magnolia Medical’s ‘483 Patent at Issue in Litigation
From Kurin, Inc.
Via Business Wire
News headline image
Kurin, Inc. Reports Record Revenue for Q3 2023
From Kurin, Inc.
Via Business Wire
News headline image
Kurin, Inc. Named 2023 Diverse Supplier of the Year by Vizient
From Kurin, Inc.
Via Business Wire
News headline image
USPTO Rejects Patent Claims Asserted by Magnolia Medical, Inc. against Kurin, Inc.
From Kurin, Inc.
Via Business Wire
News headline image
Delaware Federal Court Issues a Stay Order in Patent Dispute between Magnolia Medical and Kurin, Inc.
From Kurin, Inc.
Via Business Wire
News headline image
Kurin Launches Kurin Jet, Redefining the Blood Culture Contamination Device Market
From Kurin, Inc.
Via Business Wire
News headline image
USPTO Agrees to Kurin’s Request to Review Validity of Magnolia Medical’s ‘483 Patent
From Kurin, Inc.
Via Business Wire
News headline image
Kurin Receives 510k from the FDA with Indication to Reduce Blood Culture Contaminations
From Kurin, Inc.
Via Business Wire
News headline image
Kurin Commends the CDC for Their Recent Publication on Blood Culture Contamination
From Kurin, Inc.
Via Business Wire
News headline image
Kurin Announces Kurin Jet, A Quantum Leap Forward in Devices Designed to Address Blood Culture Contamination
From Kurin, Inc.
Via Business Wire
News headline image
Kurin, Inc. Reports Record Revenue for 2022
From Kurin, Inc.
Via Business Wire
News headline image
Kurin, Inc. Announces Successful FDA Audit
From Kurin, Inc.
Via Business Wire
News headline image
Kurin, Inc. Provides Update on Litigation Activity
From Kurin, Inc.
Via Business Wire
News headline image
Kurin, Inc. Announces Full Scale Manufacturing of Push-button Needle
From Kurin, Inc.
Via Business Wire
News headline image
Kurin, Inc. Announces Launch of Its Proprietary Push-button Needle System
From Kurin, Inc.
Via Business Wire
News headline image
Kurin, Inc. Announces Agreement with AllSpire Health GPO to Impact Contaminated Blood Cultures
From Kurin, Inc.
Via Business Wire
News headline image
Kurin, Inc. Reports Record Sales for Q4 and Total 2021 Revenues
From Kurin, Inc.
Via Business Wire
News headline image
Kurin, Inc. Reports Record Q3 Sales
From Kurin, Inc.
Via Business Wire
News headline image
Kurin, Inc. Announces UK Clinical Study Results Showing Significant Decrease in Blood Culture Contaminations With the Kurin Lock™
From Kurin, Inc.
Via Business Wire
News headline image
Kurin, Inc. Reports Record Sales Month
From Kurin, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.